» Articles » PMID: 31722732

Injecting-related Health Harms and Overuse of Acidifiers Among People Who Inject Heroin and Crack Cocaine in London: a Mixed-methods Study

Overview
Journal Harm Reduct J
Publisher Biomed Central
Specialties Pharmacology
Psychiatry
Date 2019 Nov 15
PMID 31722732
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Venous access is a priority for people who inject drugs (PWID). Damage and scarring of peripheral veins can exacerbate health harms, such as skin and soft tissue infections (SSTI), and promote transitions to femoral and subcutaneous injecting. Brown heroin available in Europe requires acidification for injection preparation. In this paper, we present mixed-methods data to explore our hypothesis of a link between overly acidic injection solutions, venous damage and SSTI risk.

Methods: We present a structured survey (n = 455) and in-depth qualitative interview (n = 31) data generated with PWID in London for the Care & Prevent study. Participants provided life history data and detail on injecting environments and drug preparation practices, including the use of acidifiers. Bivariate and multivariate analyses were conducted using a logistic regression for binary outcomes to explore associations between outcomes and excessive acidifier use. Grounded theory principles informed inductive qualitative analysis. Mixed-methods triangulation was iterative with results comparison informing the direction and questions asked of further analyses.

Results: Of the 455 participants, most (92%) injected heroin and/or crack cocaine, with 84% using citric as their primary acid for drug preparation. Overuse of acidifier was common: of the 418 who provided an estimate, 36% (n = 150) used more than ½ a sachet, with 30% (n = 127) using a whole sachet or more. We found associations between acidifier overuse, femoral injecting and DVT, but not SSTI. Qualitative accounts highlight the role of poor heroin quality, crack cocaine use, information and manufacturing constraints in acidifier overuse. Painful injections and damage to peripheral veins were common and often attributed to the use of citric acid.

Conclusions: To reduce injecting-related injury and associated consequences, it is crucial to understand the interplay of environmental and practice-based risks underpinning venous damage among PWID. Overuse of acidifier is a modifiable risk factor. In the absence of structural supports such as safe injecting facilities or the prescribing of pharmaceutical diamorphine, there is an urgent need to revisit injecting paraphernalia design and distribution in order to alleviate health harms and distress among the most marginalised.

Citing Articles

Social determinants of injection drug use-associated bacterial infections and treatment outcomes: systematic review and meta-analysis.

Brothers T, Lewer D, Bonn M, Kim I, Comeau E, Figgatt M medRxiv. 2024; .

PMID: 39398993 PMC: 11469356. DOI: 10.1101/2024.09.20.24313898.


The ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder.

J Addict Med. 2024; 18(1S Suppl 1):1-56.

PMID: 38669101 PMC: 11105801. DOI: 10.1097/ADM.0000000000001299.


Development, acceptability and feasibility of a personalised, behavioural intervention to prevent bacterial skin and soft tissue infections among people who inject drugs: a mixed-methods Person-Based Approach study.

Kesten J, Hussey D, Lord C, Roberts L, Bayliss J, Erswell H Harm Reduct J. 2023; 20(1):114.

PMID: 37608267 PMC: 10463350. DOI: 10.1186/s12954-023-00823-9.


Management of the infected arterial pseudoaneurysm secondary to groin injecting drug use and outcomes: a systematic review protocol.

MacLeod C, Radley A, Strachan D, Khan F, Nagy J, Suttie S BMJ Open. 2023; 13(6):e070615.

PMID: 37321813 PMC: 10277064. DOI: 10.1136/bmjopen-2022-070615.


Awareness of HCV Status and Preferences for Testing and Treatment among People with Recent Injecting Drug Use at a Peer-Led Needle and Syringe Program: The TEMPO Pilot Study.

Conway A, Read P, Gilliver R, McNaughton T, Valerio H, Cunningham E Viruses. 2022; 14(11).

PMID: 36366561 PMC: 9696805. DOI: 10.3390/v14112463.


References
1.
Lewer D, Harris M, Hope V . Opiate Injection-Associated Skin, Soft Tissue, and Vascular Infections, England, UK, 1997-2016. Emerg Infect Dis. 2017; 23(8):1400-1403. PMC: 5547794. DOI: 10.3201/eid2308.170439. View

2.
Harris M, Treloar C, Maher L . Staying safe from hepatitis C: engaging with multiple priorities. Qual Health Res. 2011; 22(1):31-42. DOI: 10.1177/1049732311420579. View

3.
Hope V, Ncube F, Parry J, Hickman M . Healthcare seeking and hospital admissions by people who inject drugs in response to symptoms of injection site infections or injuries in three urban areas of England. Epidemiol Infect. 2014; 143(1):120-31. PMC: 9206814. DOI: 10.1017/S0950268814000284. View

4.
Coffin P, Coffin L, Murphy S, Jenkins L, Golden M . Prevalence and characteristics of femoral injection among Seattle-area injection drug users. J Urban Health. 2012; 89(2):365-72. PMC: 3324607. DOI: 10.1007/s11524-011-9664-4. View

5.
Ebright J, Pieper B . Skin and soft tissue infections in injection drug users. Infect Dis Clin North Am. 2002; 16(3):697-712. DOI: 10.1016/s0891-5520(02)00017-x. View